As ‘Covaxin’ gets a nod from WHO, India expects more nations to give emergency approval

Delhi-On November 3, World Health Organization (WHO) gave emergency use approval for coronavirus to India’s first indigenous jab, Bharat Biotech’s ‘Covaxin’ vaccine. Hyderabad-based Bharat Biotech International Limited manufactures Covaxin. It is among six vaccines used for the nationwide inoculation drive, which started on January 16 in India. Alongside the Covishield vaccine, it is the most broadly used injection for the covid-19 immunization drive.  As most nations have opened their borders for completely immunized travellers, the Swiss government has published a list of vaccines in which they have also recognized Covaxin for international travel. As the Ministry of External Affairs (MEA)Delhi-On November 3, World Health Organization (WHO) gave emergency use approval for coronavirus to India’s first indigenous jab, Bharat Biotech’s ‘Covaxin’ vaccine. Hyderabad-based Bharat Biotech International Limited manufactures Covaxin. It is among six vaccines used for the nationwide inoculation drive, which started on January 16 in India. Alongside the Covishield vaccine, it is the most broadly used injection for the covid-19 immunization drive.  As most nations have opened their borders for completely immunized travellers, the Swiss government has published a list of vaccines in which they have also recognized Covaxin for international travel. As the Ministry of External Affairs (MEA) […]